Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Active Pharmaceutical Ingredients Market Report 2021

  • QYR676315
  • 108 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Active Pharmaceutical Ingredients

Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Teva Active Pharmaceutical Industries Limited

DSM

Novartis

Roche

Johnson?&?Johnson

Dr. Reddy’s

Pfizer

Bayer

BASF

Cambrex

Sun Pharmaceutical Industries

Lonza group

Boehringer Ingelheim GmbH

Aurobindo pharma

Lupin

Biocon

Cipla

Hisun Pharmacy

Huahai Pharmaceutical

North China Pharmaceutical Group

Shandong Lukang Pharmaceutical Co., Ltd

Haerbin Pharmaceutical Group

Shandong Xinhua Pharmaceutical Co.,Ltd

Jiangsu?Hengrui Medicine

Tian Yao

North East Pharmaceutical

Zhejiang Medicine

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Active Pharmaceutical Ingredients in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

1 Active Pharmaceutical Ingredients Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients

1.2 Classification of Active Pharmaceutical Ingredients

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Active Pharmaceutical Ingredients

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Active Pharmaceutical Ingredients Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2011-2021)

1.5.1 Europe Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)

1.5.2 Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

1.5.3 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

2 Europe Active Pharmaceutical Ingredients by Manufacturers, Type and Application

2.1 Europe Active Pharmaceutical Ingredients Market Competition by Manufacturers

2.1.1 Europe Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Active Pharmaceutical Ingredients Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Active Pharmaceutical Ingredients (Volume and Value) by Type

2.2.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)

2.2.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)

2.3 Europe Active Pharmaceutical Ingredients (Volume and Value) by Regions

2.3.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2011-2021)

2.4 Europe Active Pharmaceutical Ingredients (Volume) by Application

3 Germany Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

3.1 Germany Active Pharmaceutical Ingredients Sales and Value (2011-2021)

3.1.1 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

3.1.2 Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

3.1.3 Germany Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

3.2 Germany Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

3.3 Germany Active Pharmaceutical Ingredients Sales and Market Share by Type

3.4 Germany Active Pharmaceutical Ingredients Sales and Market Share by Applications

4 UK Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

4.1 UK Active Pharmaceutical Ingredients Sales and Value (2011-2021)

4.1.1 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

4.1.2 UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

4.1.3 UK Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

4.2 UK Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

4.3 UK Active Pharmaceutical Ingredients Sales and Market Share by Type

4.4 UK Active Pharmaceutical Ingredients Sales and Market Share by Applications

5 France Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

5.1 France Active Pharmaceutical Ingredients Sales and Value (2011-2021)

5.1.1 France Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

5.1.2 France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

5.1.3 France Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

5.2 France Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

5.3 France Active Pharmaceutical Ingredients Sales and Market Share by Type

5.4 France Active Pharmaceutical Ingredients Sales and Market Share by Applications

6 Italy Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

6.1 Italy Active Pharmaceutical Ingredients Sales and Value (2011-2021)

6.1.1 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

6.1.2 Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

6.1.3 Italy Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

6.2 Italy Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

6.3 Italy Active Pharmaceutical Ingredients Sales and Market Share by Type

6.4 Italy Active Pharmaceutical Ingredients Sales and Market Share by Applications

7 Russia Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

7.1 Russia Active Pharmaceutical Ingredients Sales and Value (2011-2021)

7.1.1 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

7.1.2 Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

7.1.3 Russia Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

7.2 Russia Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

7.3 Russia Active Pharmaceutical Ingredients Sales and Market Share by Type

7.4 Russia Active Pharmaceutical Ingredients Sales and Market Share by Applications

8 Spain Active Pharmaceutical Ingredients (Volume, Value and Sales Price)

8.1 Spain Active Pharmaceutical Ingredients Sales and Value (2011-2021)

8.1.1 Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

8.1.2 Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

8.1.3 Spain Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

8.2 Spain Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers

8.3 Spain Active Pharmaceutical Ingredients Sales and Market Share by Type

8.4 Spain Active Pharmaceutical Ingredients Sales and Market Share by Applications

9 Europe Active Pharmaceutical Ingredients Manufacturers Analysis

9.1 Teva Active Pharmaceutical Industries Limited

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Active Pharmaceutical Ingredients Product Type and Technology

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)

9.2 DSM

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Active Pharmaceutical Ingredients Product Type and Technology

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of DSM (2015 and 2016)

9.3 Novartis

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Active Pharmaceutical Ingredients Product Type and Technology

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Novartis (2015 and 2016)

9.4 Roche

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Active Pharmaceutical Ingredients Product Type and Technology

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Roche (2015 and 2016)

9.5 Johnson?&?Johnson

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Active Pharmaceutical Ingredients Product Type and Technology

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)

9.6 Dr. Reddy’s

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Active Pharmaceutical Ingredients Product Type and Technology

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)

9.7 Pfizer

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Active Pharmaceutical Ingredients Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Pfizer (2015 and 2016)

9.8 Bayer

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Active Pharmaceutical Ingredients Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Bayer (2015 and 2016)

9.9 BASF

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Active Pharmaceutical Ingredients Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of BASF (2015 and 2016)

9.10 Cambrex

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Active Pharmaceutical Ingredients Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Cambrex (2015 and 2016)

9.11 Sun Pharmaceutical Industries

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Active Pharmaceutical Ingredients Product Type and Technology

9.11.2.1 Type I

9.11.2.2 Type II

9.11.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)

9.12 Lonza group

9.12.1 Company Basic Information,Manufacturing Base and Competitors

9.12.2 Active Pharmaceutical Ingredients Product Type and Technology

9.12.2.1 Type I

9.12.2.2 Type II

9.12.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Lonza group (2015 and 2016)

9.13 Boehringer Ingelheim GmbH

9.13.1 Company Basic Information,Manufacturing Base and Competitors

9.13.2 Active Pharmaceutical Ingredients Product Type and Technology

9.13.2.1 Type I

9.13.2.2 Type II

9.13.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Boehringer Ingelheim GmbH (2015 and 2016)

9.14 Aurobindo pharma

9.14.1 Company Basic Information,Manufacturing Base and Competitors

9.14.2 Active Pharmaceutical Ingredients Product Type and Technology

9.14.2.1 Type I

9.14.2.2 Type II

9.14.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Aurobindo pharma (2015 and 2016)

9.15 Lupin

9.15.1 Company Basic Information,Manufacturing Base and Competitors

9.15.2 Active Pharmaceutical Ingredients Product Type and Technology

9.15.2.1 Type I

9.15.2.2 Type II

9.15.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Lupin (2015 and 2016)

9.16 Biocon

9.16.1 Company Basic Information,Manufacturing Base and Competitors

9.16.2 Active Pharmaceutical Ingredients Product Type and Technology

9.16.2.1 Type I

9.16.2.2 Type II

9.16.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Biocon (2015 and 2016)

9.17 Cipla

9.17.1 Company Basic Information,Manufacturing Base and Competitors

9.17.2 Active Pharmaceutical Ingredients Product Type and Technology

9.17.2.1 Type I

9.17.2.2 Type II

9.17.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Cipla (2015 and 2016)

9.18 Hisun Pharmacy

9.18.1 Company Basic Information,Manufacturing Base and Competitors

9.18.2 Active Pharmaceutical Ingredients Product Type and Technology

9.18.2.1 Type I

9.18.2.2 Type II

9.18.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Hisun Pharmacy (2015 and 2016)

9.19 Huahai Pharmaceutical

9.19.1 Company Basic Information,Manufacturing Base and Competitors

9.19.2 Active Pharmaceutical Ingredients Product Type and Technology

9.19.2.1 Type I

9.19.2.2 Type II

9.19.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Huahai Pharmaceutical (2015 and 2016)

9.20 North China Pharmaceutical Group

9.20.1 Company Basic Information,Manufacturing Base and Competitors

9.20.2 Active Pharmaceutical Ingredients Product Type and Technology

9.20.2.1 Type I

9.20.2.2 Type II

9.20.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of North China Pharmaceutical Group (2015 and 2016)

9.21 Shandong Lukang Pharmaceutical Co., Ltd

9.21.1 Company Basic Information,Manufacturing Base and Competitors

9.21.2 Active Pharmaceutical Ingredients Product Type and Technology

9.21.2.1 Type I

9.21.2.2 Type II

9.21.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Lukang Pharmaceutical Co., Ltd (2015 and 2016)

9.22 Haerbin Pharmaceutical Group

9.22.1 Company Basic Information,Manufacturing Base and Competitors

9.22.2 Active Pharmaceutical Ingredients Product Type and Technology

9.22.2.1 Type I

9.22.2.2 Type II

9.22.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Haerbin Pharmaceutical Group (2015 and 2016)

9.23 Shandong Xinhua Pharmaceutical Co.,Ltd

9.23.1 Company Basic Information,Manufacturing Base and Competitors

9.23.2 Active Pharmaceutical Ingredients Product Type and Technology

9.23.2.1 Type I

9.23.2.2 Type II

9.23.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Xinhua Pharmaceutical Co.,Ltd (2015 and 2016)

9.24 Jiangsu?Hengrui Medicine

9.24.1 Company Basic Information,Manufacturing Base and Competitors

9.24.2 Active Pharmaceutical Ingredients Product Type and Technology

9.24.2.1 Type I

9.24.2.2 Type II

9.24.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Jiangsu?Hengrui Medicine (2015 and 2016)

9.25 Tian Yao

9.25.1 Company Basic Information,Manufacturing Base and Competitors

9.25.2 Active Pharmaceutical Ingredients Product Type and Technology

9.25.2.1 Type I

9.25.2.2 Type II

9.25.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Tian Yao (2015 and 2016)

9.26 North East Pharmaceutical

9.26.1 Company Basic Information,Manufacturing Base and Competitors

9.26.2 Active Pharmaceutical Ingredients Product Type and Technology

9.26.2.1 Type I

9.26.2.2 Type II

9.26.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of North East Pharmaceutical (2015 and 2016)

9.27 Zhejiang Medicine

9.27.1 Company Basic Information,Manufacturing Base and Competitors

9.27.2 Active Pharmaceutical Ingredients Product Type and Technology

9.27.2.1 Type I

9.27.2.2 Type II

9.27.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Zhejiang Medicine (2015 and 2016)

10 Active Pharmaceutical Ingredients Technology and Development Trend

10.1 Active Pharmaceutical Ingredients Technology Analysis

10.2 Active Pharmaceutical Ingredients Technology Development Trend

11 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredients

Table Classification of Active Pharmaceutical Ingredients

Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Types in 2015

Table Applications of Active Pharmaceutical Ingredients

Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Applications in 2015

Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales of Key Manufacturers (2015 and 2016)

Table Europe Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Active Pharmaceutical Ingredients Sales Share by Manufacturers

Figure 2016 Active Pharmaceutical Ingredients Sales Share by Manufacturers

Table Europe Active Pharmaceutical Ingredients Revenue by Manufacturers (2015 and 2016)

Table Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table 2016 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers

Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales Share by Type (2011-2021)

Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Type (2011-2021)

Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)

Table Europe Active Pharmaceutical Ingredients Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate by Type (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Regions (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales Share by Regions (2011-2021)

Figure Sales Market Share of Active Pharmaceutical Ingredients by Regions (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Regions (2011-2021)

Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2011-2021)

Table Europe Active Pharmaceutical Ingredients Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Active Pharmaceutical Ingredients by Regions (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate by Regions (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Application (2011-2021)

Table Europe Active Pharmaceutical Ingredients Sales Share by Application (2011-2021)

Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2011-2021)

Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Application (2011-2021)

Figure Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Germany Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table Germany Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table Germany Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table Germany Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table Germany Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table Germany Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table Germany Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Figure UK Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure UK Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table UK Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table UK Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table UK Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table UK Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table UK Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table UK Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Figure France Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure France Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table France Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table France Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table France Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table France Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table France Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table France Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Figure Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Italy Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table Italy Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table Italy Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table Italy Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table Italy Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table Italy Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table Italy Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Figure Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Russia Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table Russia Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table Russia Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table Russia Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table Russia Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table Russia Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table Russia Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Figure Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)

Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

Figure Spain Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)

Table Spain Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)

Table Spain Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)

Table Spain Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)

Table Spain Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)

Table Spain Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)

Table Spain Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)

Table Teva Active Pharmaceutical Industries Limited Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)

Table DSM Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of DSM (2015 and 2016)

Table Novartis Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Novartis (2015 and 2016)

Table Roche Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Roche (2015 and 2016)

Table Johnson?&?Johnson Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)

Table Dr. Reddy’s Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)

Table Pfizer Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Bayer Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Bayer (2015 and 2016)

Table BASF Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of BASF (2015 and 2016)

Table Cambrex Basic Information List

Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Cambrex (2015 and 2016)

...

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370